CN104686529A - Drug combination for preventing wheat scab and application thereof - Google Patents
Drug combination for preventing wheat scab and application thereof Download PDFInfo
- Publication number
- CN104686529A CN104686529A CN201510114965.8A CN201510114965A CN104686529A CN 104686529 A CN104686529 A CN 104686529A CN 201510114965 A CN201510114965 A CN 201510114965A CN 104686529 A CN104686529 A CN 104686529A
- Authority
- CN
- China
- Prior art keywords
- sodium
- bactericidal composition
- tebuconazole
- salicylamine
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000209140 Triticum Species 0.000 title claims abstract description 39
- 235000021307 Triticum Nutrition 0.000 title claims abstract description 39
- 206010039509 Scab Diseases 0.000 title abstract description 13
- 239000000890 drug combination Substances 0.000 title 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000005839 Tebuconazole Substances 0.000 claims abstract description 29
- KPRZOPQOBJRYSW-UHFFFAOYSA-N o-hydroxybenzylamine Natural products NCC1=CC=CC=C1O KPRZOPQOBJRYSW-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000007900 aqueous suspension Substances 0.000 claims abstract description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 39
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 24
- 229940051841 polyoxyethylene ether Drugs 0.000 claims description 15
- 229920000056 polyoxyethylene ether Polymers 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 13
- LCRMGUFGEDUSOG-UHFFFAOYSA-N naphthalen-1-ylsulfonyloxymethyl naphthalene-1-sulfonate;sodium Chemical compound [Na].C1=CC=C2C(S(=O)(OCOS(=O)(=O)C=3C4=CC=CC=C4C=CC=3)=O)=CC=CC2=C1 LCRMGUFGEDUSOG-UHFFFAOYSA-N 0.000 claims description 13
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 13
- 239000000230 xanthan gum Substances 0.000 claims description 13
- 235000010493 xanthan gum Nutrition 0.000 claims description 13
- 229920001285 xanthan gum Polymers 0.000 claims description 13
- 229940082509 xanthan gum Drugs 0.000 claims description 13
- 230000000844 anti-bacterial effect Effects 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 230000000855 fungicidal effect Effects 0.000 claims description 5
- 230000002528 anti-freeze Effects 0.000 claims description 4
- 239000012752 auxiliary agent Substances 0.000 claims description 4
- 239000002270 dispersing agent Substances 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 239000013530 defoamer Substances 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- YDEXUEFDPVHGHE-GGMCWBHBSA-L disodium;(2r)-3-(2-hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulfonatopropyl)phenoxy]propane-1-sulfonate Chemical compound [Na+].[Na+].COC1=CC=CC(C[C@H](CS([O-])(=O)=O)OC=2C(=CC(CCCS([O-])(=O)=O)=CC=2)OC)=C1O YDEXUEFDPVHGHE-GGMCWBHBSA-L 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000000661 sodium alginate Substances 0.000 claims description 2
- 235000010413 sodium alginate Nutrition 0.000 claims description 2
- 229940005550 sodium alginate Drugs 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 239000002518 antifoaming agent Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 10
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 244000052769 pathogen Species 0.000 abstract 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000013329 compounding Methods 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- 231100000820 toxicity test Toxicity 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 3
- 241000223218 Fusarium Species 0.000 description 3
- 206010070863 Toxicity to various agents Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 2
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001360088 Zymoseptoria tritici Species 0.000 description 2
- 239000006013 carbendazim Substances 0.000 description 2
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000009916 joint effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 239000005843 Thiram Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000009418 agronomic effect Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- LINOMUASTDIRTM-QGRHZQQGSA-N deoxynivalenol Chemical compound C([C@@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-QGRHZQQGSA-N 0.000 description 1
- 229930002954 deoxynivalenol Natural products 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229930013292 trichothecene Natural products 0.000 description 1
- 150000003327 trichothecene derivatives Chemical class 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- LINOMUASTDIRTM-UHFFFAOYSA-N vomitoxin hydrate Natural products OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 LINOMUASTDIRTM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明涉及一种用于防治小麦赤霉病的药剂组合及其应用,所述药剂组合采用将戊唑醇和水杨菌胺进行复配,并将其制备成水悬浮剂,将其用于预防小麦赤霉病的发生和流行;通过使用药剂组合,相对于单剂来说,杀菌谱广、高效,且能有效的降低使用成本,降低病菌抗药性。The invention relates to a medicament combination for preventing and treating wheat scab and its application. The medicament combination is compounded with tebuconazole and salicylamine, prepared into a water suspension, and used for preventing The occurrence and prevalence of wheat head blight; by using a combination of agents, compared with a single agent, it has a broad spectrum of sterilization and high efficiency, and can effectively reduce the cost of use and reduce the resistance of pathogens.
Description
技术领域 technical field
本发明属于农药技术领域,涉及一种用于防治小麦赤霉病的药剂组合,更特别涉及将药剂组合配制成悬浮剂,用于小麦赤霉病的防治。 The invention belongs to the technical field of pesticides, and relates to a medicament combination for preventing and treating wheat scab, and more particularly relates to preparing the medicament combination into a suspension for the prevention and treatment of wheat scab.
技术背景 technical background
小麦赤霉病(Fusarium head blight)是影响小麦生产的重要病害。该病害主要由禾谷镰刀菌(Fusarium graminearum)等病原真菌引起,导致小麦穗枯,严重影响小麦的产量。同时,病菌在侵染过程中,可产生对人体和动物有害的脱氧雪腐镰刀菌烯醇(deoxynivalenol,NOD)单端孢霉烯醇(Trichothecenes)和玉米赤霉烯酮(Zearelanone)等真菌毒素,污染谷粒,严重影响小麦使用价值。 Wheat scab (Fusarium head blight) is an important disease affecting wheat production. The disease is mainly caused by pathogenic fungi such as Fusarium graminearum, which leads to wilted ears of wheat and seriously affects the yield of wheat. At the same time, during the infection process, the bacteria can produce mycotoxins such as deoxynivalenol (NOD), Trichothecenes and Zearelanone, which are harmful to humans and animals. , Pollution of grains seriously affects the use value of wheat.
对于小麦赤霉病的防治,目前主要通过抗品品种的选择和化学药剂防治。但在实际生产应用中,抗小麦赤霉病的品种极其缺乏,公认的仅为苏麦3号和忘水白两个品种,且这两个品种农艺性状差,难以被种植户所接受。目前在抗小麦赤霉病的品种选育方面,多集中在新抗源的筛选及苏麦3号和其它品种的杂交和聚合上,但仍处于研究阶段,离生产实际应用尚远。 The control of wheat head blight is mainly through the selection of resistant varieties and the control of chemical agents. However, in actual production and application, varieties resistant to wheat scab are extremely scarce. The only recognized varieties are Sumai 3 and Wangshuibai, and these two varieties have poor agronomic traits and are difficult to be accepted by growers. At present, in the breeding of varieties resistant to wheat head blight, most of them focus on the screening of new resistance sources and the hybridization and aggregation of Sumai 3 and other varieties, but it is still in the research stage and is far from practical application in production.
对于小麦赤霉病的化学防治,可供选择的药剂较少,其中戊唑醇是主要使用的药剂之一。但长期大规模使用后,易造成赤霉病菌对戊唑醇产生抗药性。开展戊唑醇与其它作用机理不同的药剂复配是延缓抗药性的重要措施之一。在已知的复配药剂中,戊唑醇多与多菌灵、福美双等一些老药剂进行复配,长期应用易于导致小麦赤霉病菌产生多抗性,急需寻找新的药剂与戊唑醇进行复配,以降低多抗性产生的风险。 For the chemical control of wheat head blight, there are few agents to choose from, among which tebuconazole is one of the main agents used. However, after long-term large-scale use, it is easy to cause resistance of gibberella to tebuconazole. Developing the combination of tebuconazole and other agents with different mechanisms of action is one of the important measures to delay drug resistance. Among the known compound agents, tebuconazole is mostly compounded with some old agents such as carbendazim and thiram. Long-term use is likely to lead to multi-resistance of wheat scab. It is urgent to find new agents and tebuconazole Compounding is carried out to reduce the risk of multi-resistance.
水杨菌胺为广谱的杀真菌剂,对包括镰刀菌在内的多种真菌具有极强的抑制效果,且毒性极低,适宜于小麦赤霉病的防治。目前,尚未发现将戊唑醇与水杨菌胺进行复配用于小麦赤霉病的防治的相关报道。 Salicylamine is a broad-spectrum fungicide, which has a strong inhibitory effect on a variety of fungi including Fusarium, and has extremely low toxicity, which is suitable for the control of wheat head blight. At present, there is no relevant report on the compounding of tebuconazole and salicylamine for the control of wheat head blight.
发明内容 Contents of the invention
本发明将戊唑醇和水杨菌胺进行复配,并将其制备成水悬浮剂,预防小麦赤霉病的发生和流行。 In the invention, the tebuconazole and salicylamine are compounded and prepared into a water suspension to prevent the occurrence and prevalence of wheat scab.
基于这一目的,本发明的技术方案为:一种杀菌组合物,其特征在于,所述杀菌组合物的有效成分为戊唑醇与水杨菌胺的复配组合物,二者的重量比为1:4~4:1。 Based on this purpose, the technical solution of the present invention is: a bactericidal composition, characterized in that the active ingredient of the bactericidal composition is a compound composition of tebuconazole and salicylamine, and the weight ratio of the two is 1:4 to 4:1.
优选地,二者的重量比为1:1~4:1;更优选地,二者的重量比为4:1。 Preferably, the weight ratio of the two is 1:1˜4:1; more preferably, the weight ratio of the two is 4:1.
进一步地,本发明的涉及一种水悬浮剂,其特征在于包含5%~60%的上述杀菌组合物和助剂,助剂为润湿剂0.2~5wt%、乳化分散剂2%~10%,增稠剂0.1%~3%,防冻剂3%~5%,消泡剂0.4%~5%,其余用水补足100%,所述%为重量百分比。 Further, the present invention relates to an aqueous suspension, which is characterized in that it contains 5% to 60% of the above-mentioned bactericidal composition and auxiliary agents, and the auxiliary agents are 0.2% to 5% by weight of wetting agent and 2% to 10% of emulsifying and dispersing agent , 0.1% to 3% of thickener, 3% to 5% of antifreeze, 0.4% to 5% of defoamer, and make up 100% of the rest with water, and said % is weight percentage.
所述润湿剂为十二烷基硫酸钠、十二烷基苯磺酸钠及拉开粉中的一种或多种的组合。 The wetting agent is a combination of one or more of sodium dodecylsulfate, sodium dodecylbenzenesulfonate and pull-off powder.
所述乳化分散剂为亚甲基双萘磺酸钠、木质素磺酸钠、烷基酚聚氧乙烯醚、多芳基酚聚氧乙烯醚磷酸酯中的一种或者多种的组合。 The emulsifying dispersant is one or more combinations of sodium methylene bis-naphthalene sulfonate, sodium lignin sulfonate, alkylphenol polyoxyethylene ether, polyarylphenol polyoxyethylene ether phosphate.
所述增稠剂为黄原酸胶、海藻酸钠、瓜尔豆胶和羧甲基纤维素钠中的一种或混合物。 The thickener is one or a mixture of xanthan gum, sodium alginate, guar gum and sodium carboxymethylcellulose.
所述防冻剂为乙二醇。 The antifreeze is ethylene glycol.
所述消泡剂为正辛醇。 The defoamer is n-octanol.
优选地,杀菌组合物的用量为20~50%;更优选地,杀菌组合物的用量为40%。 Preferably, the amount of the bactericidal composition is 20-50%; more preferably, the amount of the bactericidal composition is 40%.
除非另有说明,本说明书中的“%”均为“重量百分比”。 Unless otherwise specified, "%" in this specification is "percentage by weight".
进一步地,本发明还涉及将上述杀菌组合物或水悬浮剂用于防治小麦赤霉病的用途。 Further, the present invention also relates to the use of the above-mentioned fungicidal composition or aqueous suspension for preventing and treating wheat head blight.
本申请水悬浮剂的制备方法:将计量好的各成分按比例投入乳化剪切机中;高速剪切30分钟,即可得到该产品,稀释后喷雾使用。 The preparation method of the water-suspending agent of the present application: Put the measured components into an emulsifying shearing machine in proportion; shear at a high speed for 30 minutes to obtain the product, and spray it for use after dilution.
本发明的杀菌组合物或水悬浮剂所用有效成分为低毒药剂,对非靶标生物和环境安全,对人畜无害,适合在小麦上使用,能有效地预防和治疗小麦赤霉病的发生和流行。同时,使用混配剂型,相对于单剂来说,杀菌谱广、高效,且能有效的降低使用成本,降低病菌抗药性。 The active ingredients used in the fungicidal composition or aqueous suspension of the present invention are low-toxic agents, which are safe to non-target organisms and the environment, harmless to humans and animals, are suitable for use on wheat, and can effectively prevent and treat the occurrence and treatment of wheat scab. Popularity. At the same time, using a mixed dosage form, compared with a single agent, has a broad spectrum of sterilization and high efficiency, and can effectively reduce the cost of use and reduce the resistance of bacteria.
具体实施方式 Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,本发明用以下具体实例进行说明,但本发明不局限于这些具体实施例。 In order to make the object, technical solution and advantages of the present invention more clear, the present invention is illustrated with the following specific examples, but the present invention is not limited to these specific examples.
制备实施例 Preparation Example
实施例1: Example 1:
戊唑醇8wt%;水杨菌胺32wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 8wt%; Salicylamine 32wt%; Sodium dodecylbenzene sulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例2: Example 2:
戊唑醇10wt%;水杨菌胺30wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 10wt%; Salicylamine 30wt%; Sodium dodecylbenzenesulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例3: Example 3:
戊唑醇13wt%;水杨菌胺27wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 13wt%; Salicylamine 27wt%; Sodium dodecylbenzene sulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例4: Example 4:
戊唑醇20wt%;水杨菌胺20wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 20wt%; Salicylamine 20wt%; Sodium dodecylbenzenesulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例5: Example 5:
戊唑醇27wt%;水杨菌胺13wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 27wt%; Salicylamine 13wt%; Sodium dodecylbenzenesulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例6: Embodiment 6:
戊唑醇30wt%;水杨菌胺10wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 30wt%; Salicylamine 10wt%; Sodium dodecylbenzene sulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例7: Embodiment 7:
戊唑醇32wt%;水杨菌胺8wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 32wt%; Salicylamine 8wt%; Sodium dodecylbenzene sulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例8: Embodiment 8:
戊唑醇8wt%;水杨菌胺2wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 8wt%; Salicylamine 2wt%; Sodium dodecylbenzenesulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例9: Embodiment 9:
戊唑醇16wt%;水杨菌胺4wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 16wt%; Salicylamine 4wt%; Sodium dodecylbenzene sulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例10: Example 10:
戊唑醇40wt%;水杨菌胺10wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 40wt%; Salicylamine 10wt%; Sodium dodecylbenzene sulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
实施例11: Example 11:
戊唑醇48wt%;水杨菌胺12wt%;十二烷基苯磺酸钠2wt%,亚甲基双萘磺酸钠3wt%;烷基酚聚氧乙烯醚1.5wt%;黄原胶0.5wt%;乙二醇3%;正辛醇3wt%;余量用水补足。 Tebuconazole 48wt%; Salicylamine 12wt%; Sodium dodecylbenzene sulfonate 2wt%, Sodium methylene bis-naphthalene sulfonate 3wt%; Alkylphenol polyoxyethylene ether 1.5wt%; Xanthan gum 0.5 wt%; ethylene glycol 3%; n-octanol 3wt%; the balance is made up with water.
一、生物实施例 One, biological embodiment
1、室内杀菌活性测定 1. Determination of indoor bactericidal activity
1.1药剂毒力测定 1.1 Drug toxicity determination
参照农药室内生物测定试验准则,采用生长速率抑制法测定供试单剂对小麦赤霉病病菌菌丝生长的抑制作用。将不同浓度的药液与融化的PDA培养基混合,制成相应浓度梯度的含药培养基平板,以不添加药液的PDA平板为空白对照,各浓度重复3次。 Referring to the indoor bioassay test guidelines for pesticides, the growth rate inhibition method was used to determine the inhibitory effect of the tested single agent on the mycelium growth of wheat head blight. Mix different concentrations of medicinal liquid with melted PDA medium to make a drug-containing medium plate with a corresponding concentration gradient. The PDA plate without medicinal liquid was used as a blank control, and each concentration was repeated 3 times.
用打孔器打取小麦赤霉病菌(直径4mm)的菌饼,接种到不同浓度的含药PDA平板中央。置于27℃恒温箱内培养至空白对照菌落直径达到培养皿的2/3时,用十字交叉法测量菌落直径,计算出各自的抑制率。 Get the bacterium cake of wheat scab (diameter 4mm) with puncher, inoculate to the center of the PDA plate containing medicine of different concentrations. Place in a 27°C incubator and cultivate until the diameter of the blank control colony reaches 2/3 of the culture dish, measure the diameter of the colony with the cross method, and calculate the respective inhibition rates.
将生长抑菌率换成抑制机率值并作为纵坐标,药剂质量浓度转化为对数值作为横坐标,根据抑菌率进行机率值(y)与质量浓度对数(x)之间的线性回归关系,求毒力回归方程,计算EC50值及相关系数r等。 Change the growth inhibition rate into the inhibition probability value and use it as the ordinate, transform the drug mass concentration into a logarithm value as the abscissa, and perform the linear regression relationship between the probability value (y) and the mass concentration logarithm (x) according to the bacteriostatic rate , seek toxicity regression equation, calculate EC 50 value and correlation coefficient r, etc.
1.2水杨菌胺和戊唑醇的复配作用研究 1.2 Research on compounding effect of salicylamine and tebuconazole
将水杨菌胺和戊唑醇进行复配:将两种原药按有效成分配制成4:1,3:1,2:1,1:1,1:2,1:3,1:4共7个配比(质量比)。上述配方分别按药剂毒力测定方法进行毒力测定。 Compounding salicylamine and tebuconazole: the two original drugs are prepared according to the active ingredients in 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1: 4 7 proportioning ratios (mass ratios) in total. The above formulations were tested for toxicity according to the drug toxicity test method.
对混剂联合作用进行评价,以EC50值为基础,通过计算混剂共毒系数评价混剂联合作用类型。 To evaluate the joint effect of the mixture, based on the EC 50 value, the type of joint effect of the mixture was evaluated by calculating the co-toxicity coefficient of the mixture.
CTC≥120为增效作用,80≤CTC<120为相加作用,CTC<80为拮抗作用。 CTC≥120 is a synergistic effect, 80≤CTC<120 is an additive effect, and CTC<80 is an antagonistic effect.
2.试验结果 2. Test results
2.1药剂毒力测定结果 2.1 Drug toxicity test results
表1 2种农药原药对小麦赤霉病菌的室内毒力测定结果 Table 1 Indoor toxicity test results of two kinds of pesticide technical substances against wheat head blight
从表1可以看出,戊唑醇对小麦赤霉病菌的EC50为2.9198μg/mL;水杨菌胺对小麦赤霉病菌的EC50为21.1244μg/mL。 It can be seen from Table 1 that the EC 50 of tebuconazole against S. tritici is 2.9198 μg/mL; the EC 50 of salicylamine against S. tritici is 21.1244 μg/mL.
表2戊唑醇与水杨菌胺复配对小麦赤霉病菌的室内毒力测定结果 Table 2 Indoor toxicity test results of tebuconazole and salicylamine compound against wheat head blight
由表2可知,戊唑醇和水杨菌胺复配的所有比例均表现出一定的增效作用,但不同复配比例增效系数有所差异。其中,戊唑醇和水杨菌胺的复配比例为4:1时,共毒系数最高,为161.56。 It can be seen from Table 2 that all proportions of the compounded tebuconazole and salicylamine showed a certain synergistic effect, but the synergistic coefficients of different compounded proportions were different. Among them, when the compound ratio of tebuconazole and salicylamine was 4:1, the co-toxicity coefficient was the highest, which was 161.56.
二、大田实验 2. Field experiment
1.试验方法 1. Test method
在小麦扬花期进行田间喷雾施药,各实施例稀释3000倍液使用,试验每处理4次重复。以50%多菌灵WP稀释1000倍液为药剂对照,以清水作为空白对照。在小麦乳熟期调查小麦赤霉病病发病情况。每小区对角线5点调查,每点调查调查100株。采用分级计数法,按照病情分级标准对每穗病情进行统计。同时观察施药对小麦生长的影响。 Field spraying was carried out at the flowering stage of wheat, and each embodiment was diluted 3000 times for use, and the test was repeated 4 times for each treatment. 50% carbendazim WP diluted 1000 times was used as drug control, and clear water was used as blank control. Investigate the incidence of wheat head blight in wheat milk stage. 5 points on the diagonal of each plot were surveyed, and 100 plants were surveyed at each point. The disease condition of each panicle was counted according to the disease grading standard by graded counting method. At the same time, the effect of pesticide application on wheat growth was observed.
分级方法: Grading method:
0级:无病 Level 0: no disease
1级:病小穗占全部的1/4以下。 Grade 1: less than 1/4 of the diseased spikelets.
2级:病小穗占全部的1/4~1/2。 Grade 2: Diseased spikelets account for 1/4 to 1/2 of the total.
3级:病小穗占全部的1/2~3/4。 Grade 3: Diseased spikelets account for 1/2 to 3/4 of the total.
4级:病小穗占全部的3/4以上。 Grade 4: Diseased spikelets account for more than 3/4 of the total.
药效计算方法 Pharmacological Calculation Method
式中:CK——空白对照区病情指数; In the formula: CK—the condition index of the blank control area;
PT——药剂处理区病情指数; PT—the condition index of the drug treatment area;
2.试验结果 2. Test results
由表3可以看出,不同实施例对小麦赤霉病均有不同程度的防治作用。其中,当戊唑醇和水杨菌胺有效成分为40wt%,在两者配比为4:1时(实施例7),对小麦赤霉病防治效果最好,高于其它配比(实施例1,实施例2,实施例3,实施例4,实施 例5和实施例6和对照药剂处理),且对小麦生长无明显的影响。当有效成分含量低于40wt%时(实施例8和实施例9),对小麦赤霉病的防治效果明显下降;当有效成分含量高于40wt%时(实施例10和实施例11),对小麦赤霉病的防治效果无明显改变。由此可以看出,当戊唑醇和水杨菌胺有效成分为40wt%,且两者配比为4:1为最佳有效成分含量和配比,对小麦赤霉病有很好的防治效果。 As can be seen from Table 3, different embodiments all have different degrees of control effects on wheat scab. Wherein, when the active ingredients of tebuconazole and salicylamine are 40wt%, when the ratio of the two is 4:1 (Example 7), the control effect on wheat head blight is the best, which is higher than other ratios (Example 7). 1, embodiment 2, embodiment 3, embodiment 4, embodiment 5 and embodiment 6 and contrast agent treatment), and have no obvious impact on wheat growth. When active ingredient content was lower than 40wt% (embodiment 8 and embodiment 9), the control effect to wheat head blight obviously declined; when active ingredient content was higher than 40wt% (embodiment 10 and embodiment 11), to There was no significant change in the control effect of wheat head blight. It can be seen that when the active ingredients of tebuconazole and salicylamine are 40wt%, and the ratio of the two is 4:1, it is the best content and ratio of active ingredients, and it has a good control effect on wheat head blight .
表3不同实施例处理防治小麦赤霉病的田间效果 Table 3 Field Effects of Different Embodiments Handling Control of Wheat Scab
本发明的一种用于防治小麦赤霉病已通过具体的实施例进行了描述。本领域技术人员可以借鉴本发明的内容适当改变原料、工艺条件等环节来实现相应的其它目的,其相关改变都没有脱离本发明的内容,所有类似的替换和改动对于本领域技术人员来说是显而易见的,都被视为包括在本发明的范围之内。 A method of the present invention for controlling wheat scab has been described through specific examples. Those skilled in the art can learn from the content of the present invention to appropriately change links such as raw materials and process conditions to achieve other corresponding goals, and the relevant changes do not depart from the content of the present invention. All similar replacements and changes are considered by those skilled in the art Obviously, all are considered to be included within the scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510114965.8A CN104686529B (en) | 2015-03-16 | 2015-03-16 | Combination of agents for preventing and treating wheat scab and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510114965.8A CN104686529B (en) | 2015-03-16 | 2015-03-16 | Combination of agents for preventing and treating wheat scab and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104686529A true CN104686529A (en) | 2015-06-10 |
CN104686529B CN104686529B (en) | 2016-11-02 |
Family
ID=53334427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510114965.8A Expired - Fee Related CN104686529B (en) | 2015-03-16 | 2015-03-16 | Combination of agents for preventing and treating wheat scab and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104686529B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101663032A (en) * | 2007-04-20 | 2010-03-03 | 拜尔农作物科学股份公司 | Use of fungicides for treating fish mycoses |
EP2269454A1 (en) * | 2009-06-24 | 2011-01-05 | Bayer CropScience AG | Combinations of fungicidally active yeast and fungicides |
US20140357679A1 (en) * | 2009-09-14 | 2014-12-04 | Thomas Seitz | Active compound combinations |
-
2015
- 2015-03-16 CN CN201510114965.8A patent/CN104686529B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101663032A (en) * | 2007-04-20 | 2010-03-03 | 拜尔农作物科学股份公司 | Use of fungicides for treating fish mycoses |
EP2269454A1 (en) * | 2009-06-24 | 2011-01-05 | Bayer CropScience AG | Combinations of fungicidally active yeast and fungicides |
US20140357679A1 (en) * | 2009-09-14 | 2014-12-04 | Thomas Seitz | Active compound combinations |
Non-Patent Citations (4)
Title |
---|
吴学宏等: ""含戊唑醇种衣剂防治小麦苗期纹枯病的研究"", 《莱阳农学院学报》, vol. 17, no. 2, 30 June 2000 (2000-06-30), pages 93 - 97 * |
张玉等: ""50%真菌灵防治西瓜枯萎病的药效试验"", 《安徽农业科学》, no. 3, 25 June 1999 (1999-06-25) * |
王汉成等: ""戊唑醇对立枯丝核菌的抑制作用及在水稻上的应用"", 《农药学学报》, vol. 9, no. 4, 15 December 2007 (2007-12-15), pages 357 - 362 * |
邹方姜等: ""50%多·霉威可湿性粉剂(瓜老爷)防治西瓜枯萎病田间药效试验"", 《安徽农业·植物保护》, no. 9, 28 September 2004 (2004-09-28), pages 27 * |
Also Published As
Publication number | Publication date |
---|---|
CN104686529B (en) | 2016-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103960244B (en) | Bactericidal composition containing Shen piperazine mycin | |
CN103999858B (en) | Bactericidal composition containing cycloflufen and acetoallin | |
CN113951273A (en) | Bactericidal composition for preventing and treating southern blight | |
CN105010357A (en) | Sterilization composition and application thereof | |
CN104304325B (en) | A kind of kind Rhizoma Zingiberis Recens inorganic agent preventing bacterial wilt of ginger | |
CN1327770C (en) | Sterilization composition containing carbendazim of multiple antimycin | |
CN100488363C (en) | Germicide containing thiophanate-methyl and prochloraz | |
CN104686529B (en) | Combination of agents for preventing and treating wheat scab and its application | |
CN102972410B (en) | Pesticide composition containing prothioconazole and methoxyl acrylic ester bactericides | |
CN104115841A (en) | Fungicide composition containing fludioxonil and application thereof | |
CN104115869A (en) | Ternary compound pesticide containing copper hydroxide, trifloxystrobin and tebuconazole | |
CN108157381A (en) | Bactericidal composition containing captan and isopyrazam | |
CN110402937B (en) | Bactericide composition containing bixafen and dimoxystrobin and application thereof | |
CN103039492B (en) | Pesticide compound bactericide | |
CN107041382A (en) | A kind of efficient bactericidal composite containing bacillus amyloliquefaciens | |
CN101444213A (en) | Desinsection composite and application thereof | |
CN115956568B (en) | A kind of bactericidal composition containing flutriafol | |
CN104273126B (en) | A kind of bactericidal composition preventing and treating rice sheath blight disease | |
CN110973147A (en) | Bactericidal composition for preventing and treating peanut leaf spot disease, application thereof and bactericide | |
CN103141483B (en) | Sterilization compound containing mepanipyrim and validamycin | |
CN101755786B (en) | Bactericidal composition | |
CN103141495B (en) | A kind of bactericidal composition containing carbendazim and mepanipyrim | |
CN107047618A (en) | A kind of bactericidal composition containing bacillus amyloliquefaciens | |
CN108294029A (en) | A kind of composition pesticide containing folpet | |
CN105941483A (en) | Compound pesticide containing Zhongshengmycin and copper hydroxide and application of compound pesticide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161102 Termination date: 20170316 |
|
CF01 | Termination of patent right due to non-payment of annual fee |